Safety Alerts and Products Recalls
>
Other safety alerts
Other safety alerts
The United Kingdom: IXCHIQ Chikungunya vaccine: updates to restrictions of use following safety review
Attachment:
IXCHIQ Chikungunya vaccine
Related Information:
European Union: PRAC warns about known risk of aseptic meningitis with chikungun...
Posted 2026-03-14
Canada: Health professional risk communication: IXCHIQ (chikungunya vaccine, liv...
Posted 2026-03-10
The United States: FDA update on the safety of Ixchiq (Chikungunya Vaccine, Live...
Posted 2025-08-26
The United States: FDA update on the safety of Ixchiq (Chikungunya Vaccine, Live...
Posted 2025-08-07
European Union: Ixchiq: temporary restriction on vaccinating people 65 years and...
Posted 2025-07-26
European Union: Ixchiq: Vaccine to be used only when there is a significant chik...
Posted 2025-07-12
The United Kingdom: IXCHIQ Chikungunya vaccine: temporary suspension in people a...
Posted 2025-06-19
The United Kingdom: Chikungunya vaccine (IXCHIQ) temporarily paused in people ag...
Posted 2025-06-10
The United States: FDA and CDC recommend pause in use of Ixchiq (Chikungunya Vac...
Posted 2025-05-13
European Union: EMA starts review of Ixchiq (live attenuated chikungunya vaccine...
Posted 2025-05-08